About Koninklijke Philips N.V. NY Registry Shares (PHG)
Koninklijke Philips Electronics is a global leader in health technology, focused on improving people's lives through meaningful innovation. The company develops a wide range of products and solutions, including medical devices, diagnostic imaging, patient monitoring systems, and consumer health products. Its commitment to enhancing healthcare and well-being extends into areas such as personal health, connected care, and sustainable development, aiming to deliver integrated solutions that empower both health professionals and patients. Philips combines advanced technologies with deep clinical and consumer insights to create solutions that drive better outcomes and improve the quality of care across various settings. Read More
November 17, 2025Innovation uses AI to track and visualize tiny repair devices* through the beating heart, helping clinicians navigate in 3D with enhanced clarity and confidence**Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today introduced DeviceGuide, an AI-powered device tracking* solution that assists physicians during one of interventional cardiology’s most technically demanding procedures: repairing leaking heart valves through a minimally invasive approach. Built on Philips’ EchoNavigator platform, this software brings AI directly into the procedure room, translating complex imaging into intuitive, real-time visual guidance that helps clinicians navigate the beating heart with greater clarity and confidence. It will be previewed at London Valves 2025 (November 16-18), one of the world’s leading meetings for structural heart specialists.“With DeviceGuide, we’re bringing AI into the heart of the procedure room, and into the heart itself,” said Dr. Atul Gupta, Chief Medical Officer, Diagnosis & Treatment at Philips. “This is Philips’ first AI assisting physicians in real time to visualize and guide heart valve treatment devices* as they navigate the beating heart. It’s helping doctors in the moment as they are helping their patients with structural heart disease.”Minimally invasive treatment of the mitral valveA leaking heart valve, known as mitral valve regurgitation, is a condition in which blood leaks backward through the heart’s mitral valve. It affects more than 35 million [1] adults worldwide, leaving many short of breath, fatigued, and struggling with everyday activities like climbing stairs or walking short distances. Many also live with anxiety or fear, knowing their heart isn’t pumping efficiently. If left untreated, severe cases can lead to heart failure and other serious complications.For patients who are too frail for open-heart surgery, minimally invasive transcatheter repair techniques such as mitral transcatheter edge-to-edge repair (M-TEER) offer a vital treatment option. During these procedures, physicians repair a leaking valve through a tiny incision in the top of the leg in the groin area, guiding long, flexible instruments through the blood veins and navigating a miniature repair device into the beating heart.Clinicians must view and interpret both X-ray and ultrasound images on multiple screens, coordinate movements between two operators, and make precise adjustments to grasp the moving valve leaflets, position the repair device, and confirm the result in real time. The process demands accuracy, coordination, and experience from the team. This is where DeviceGuide can help with its 3D navigation support.How AI is helpingDeviceGuide uses an AI algorithm to automatically track the tiny repair device as it moves through the beating heart, intelligently combining live echo and X-ray images. It creates a virtual 3D model of the treatment device in real time, superimposed on the live images of the beating heart. This allows clinicians to see where the device is and in which direction it is pointing, providing a clear view of the procedure and potentially enabling them to navigate the device more easily to effectively seal the leak.“The AI software serves as an assistive tool, with the physician always remaining in control. This isn’t about replacing expertise – it’s about amplifying it,” added Dr. Atul Gupta. “By embedding AI into the procedure, DeviceGuide gives physicians an extra pair of eyes, effectively bionic vision, helping them treat more patients safely and confidently.”Collaboration with Edwards LifesciencesThis innovation was developed in close collaboration with Edwards Lifesciences, the manufacturer of these repair devices. The solution combines Philips’ expertise in medical imaging and AI technologies with Edwards’ global leadership in structural heart innovation. Together, the companies have reimagined key parts of the mitral TEER procedural workflow.“DeviceGuide demonstrates the impact of combining leading imaging and therapy expertise to develop solutions designed around the procedural workflow, a model that will shape the future of AI-enabled image-guided structural interventions,” said Mark Stoffels, Business Leader, Image Guided Therapy Systems.This solution illustrates how Philips’ imaging and AI expertise can merge with the insights of leading therapy companies to innovate procedural workflows. This kind of collaboration is a model for developing the next generation of AI-enabled, image-guided innovations, centered on the needs of clinicians and their patients.Read more on how Philips DeviceGuide works here.
Artificial intelligence (AI) is rapidly transcending its origins within the technology sector, becoming an indispensable force that is fundamentally reshaping traditional industries. From the intricacies of healthcare to the precision of manufacturing, the sustainability of agriculture, the dynamism of finance, and the complexity of logistics, AI is driving unprecedented levels of efficiency, innovation, and strategic [...]
The financial markets are currently witnessing a compelling narrative unfold as the US dollar experiences a significant softening, directly correlating with a remarkable surge in gold prices. This inverse relationship, a long-standing tenet of commodity economics, has propelled the precious metal above critical psychological thresholds, with spot gold trading around
Recent breakthroughs in multimodal Artificial Intelligence (AI) are fundamentally reshaping the landscape of cancer research, ushering in an era of unprecedented precision in diagnosis and personalized treatment. By intelligently integrating diverse data types—from medical imaging and genomic profiles to clinical notes and real-world patient data—these advanced AI systems offer a holistic and nuanced understanding of [...]
Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced its support of the Forever Promise Project, an initiative of the Monuments Men and Women Foundation that connects American families of fallen World War II service members with the Dutch citizens who have lovingly adopted their graves at the Netherlands American Cemetery in Margraten. Philips will help advance the Foundation’s mission to connect all 10,000 American families with their Dutch adopters, fostering meaningful relationships across generations and borders. As part of this collaboration, Philips employees will have the opportunity to participate in volunteer activities that support the project.
October 27, 2025 New integration of Philips Advanced Visualization Workspace* with the Azurion image-guided therapy platform automatically synchronizes CT images with C-arm movement, supporting workflow efficiency and additional anatomical insights in PCI procedures1
Minneapolis, MN – October 13, 2025 – Inspire Medical Systems (NYSE: INSP) emerged as a standout performer in today's trading session, witnessing its stock price jump by an impressive 3.9% by the closing bell. This significant surge is primarily attributed to the overwhelmingly positive clinical outcomes data presented for its next-generation
CHICAGO, IL – October 2, 2025 – The Radiological Society of North America (RSNA) today announced the official launch of RSNA Ventures, a groundbreaking mission-aligned subsidiary poised to revolutionize the landscape of radiology and imaging technology. This strategic initiative aims to actively identify, accelerate, and support groundbreaking ideas that promise to enhance
The healthcare landscape is undergoing a profound transformation, driven by an accelerating wave of technological innovation. Far beyond the traditional clinic walls, digital solutions are reshaping how patients interact with providers and how environments are safeguarded against unseen threats. Two pivotal advancements, messaging-oriented care and advanced air purification systems, stand
Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology and Southlake Health, today announced that the healthcare provider has selected Philips Ambition X MR with BlueSeal technology, the first high-performance and eco-friendly helium-free 1.5T scanner, to advance its diagnostic imaging capabilities with improved workflow efficiency and expanded imaging programs [1]. By implementing this leading-edge technology, Southlake Health has decreased scan times and improved patient throughput for some exams, benefiting the communities Southlake serves and the hospital’s dedicated healthcare professionals. For over 20 years, Southlake has relied on Philips imaging technology and services to maintain its MRI’s peak performance.
In an innovative initiative to improve disaster preparedness and response, Philips, Philips Foundation, and nonprofit MedShare International are collaborating to tackle the healthcare challenges caused by natural disasters.
The investment includes the expansion of the company’s Reedsville, PA, site and the recently announced expansion of the Image Guided Therapy facility in Plymouth, MN, the company said.
